Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More
Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa
Wednesday, February 21 2024 | 07 h 53 min | Vision Science
A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...
Read More
Stargardt Disease
Thursday, January 18 2024 | 07 h 28 min | Vision Science
Stargardt disease is a rare genetic eye disease that happens when fatty material builds up on the macula Vision loss usually starts in...
Read More
Cone-Rod Dystrophy
Wednesday, November 29 2023 | 08 h 21 min | Vision Science
A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa Beacon...
Read More
Clinical Trial Launched to Test New Drug for AMD and DME
Wednesday, November 15 2023 | 13 h 50 min | Vision Science
Fighting Blindness Canada funded researcher Dr Sachdev Sidhu (University of Waterloo) has developed a novel antibody therapy that will now be tested...
Read More
